ghk-cu peptide supplement GHK Copper | GHK-Cu Copper Peptide Supplement, 300
Description
Authors contributions IP: Writing of the manuscript, study design, data collection and interpretation, preparation of revisions
MATERIALS AND METHODS Patients Patients with a molecularly confirmed diagnosis of clEDS were identified through the national complex EDS service in London and Sheffield or through collaborations
Just go with it

Slow Responders (15-20% of users): May not notice meaningful changes until week 3 or 4, with peak benefit reached around week 8 to 10
